Navigation Links
Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board
Date:8/26/2014

Hopkins School of Medicine. He completed his Internal Medicine internship and residency training, and his subspecialty clinical and research training in Infectious Diseases and Virology at the Massachusetts General Hospital (M.G.H.) of the Harvard Medical School and was selected and served as the Chief Medical Resident at M.G.H. His post-doctoral research training in Molecular Retrovirology was obtained at both the Harvard Medical School and the Whitehead Institute of the Massachusetts Institute of Technology. Roger was Professor of Medicine, Biochemistry and Molecular Pharmacology, Chief of Infectious Diseases, and the Founding Director and Chair of the Institute for Human Virology and Biodefense at the Thomas Jefferson University and Medical School.

About NVR-1221

NVR-1221 is a small molecule, direct-acting antiviral, for oral administration in patients with Chronic Hepatitis B (CHB) that inhibits the HBV core or capsid protein. HBV core is a novel and promising drug target with multiple activities required for viral replication and persistence. Inhibition of HBV core protein function by NVR-1221 offers the potential for a more efficient suppression of the virus leading to improved durable viral suppression and functional cure rates.

NVR-1221 is in Phase 1a clinical studies in New Zealand following successful completion of the Clinical Trial Application (CTA) regulatory process. The Phase 1a clinical study will investigate the dose-related safety/tolerance and pharmacokinetics (PK) of NVR-1221 in approximately 40 healthy volunteers. Upon completion and satisfactory outcome of the Phase 1a clinical study, Novira will commence a Phase 1b clinical study to test the safety, PK and initial antiviral activity of NVR-1221 in patients with chronic HBV infection.

About HBV

Hepatitis B infection presents a significant unmet medical need with an estimated 350 million people worldwide living with chronic HBV infecti
'/>"/>

SOURCE Novira Therapeutics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novira Therapeutics Expands Management Team with Appointment of Klaus Klumpp, Ph.D., the Former Global Head of Roches Virology Discovery Initiatives, as Vice President Discovery Research
2. MultiCell Technologies Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer
3. Asterias Biotherapeutics Announces Investor Briefing Conference Call and Webcast
4. Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day
5. Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer
6. Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution
7. PTC Therapeutics to Participate at Upcoming Investor Conferences
8. Data Published by Researchers from The Scripps Research Institute Demonstrate Potential for MYC Inhibitor Licensed by Sorrento Therapeutics
9. Echo Therapeutics, Inc. Announces Second Quarter 2014 Financial Results and Provides Business Update
10. Aratana Therapeutics Reports Second Quarter 2014 Results
11. Mirati Therapeutics Receives Orphan Designation from U.S. Food & Drug Administration for Mocetinostat in Diffuse Large B-Cell Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... Ga. , July 6, 2015  EndoChoice Holdings, ... its second quarter 2015 financial results on Thursday, August ... EndoChoice will hold a conference call on Thursday, August ... results. The dial-in numbers are (866) 807-9684 for domestic ... webcast of the conference call will be available on ...
(Date:7/6/2015)... July 6, 2015  Nitin Tandon, M.D., UTHealth ... Memorial Hermann Mischer Neuroscience Institute at ... RNS® System technology into the skull of a ... of seizures – the first time this procedure ... "Epilepsy is a neurological condition that affects ...
(Date:7/6/2015)... 6, 2015 Mauna Kea ... multidisciplinary confocal laser endomicroscopy platform, announced today it ... Ministry of Health, Labor and Welfare (MHLW) ... the AQ-Flex 19 miniprobe.   Used ... miniprobe is comprised of a fiber-optic microscope that ...
Breaking Medicine Technology:EndoChoice to Report Second Quarter 2015 Financial Results on August 6, 2015 2Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 2Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 3Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 4Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3
... REDWOOD CITY, Calif., Feb. 6, 2012 Cardica, Inc. (Nasdaq: ... fiscal second quarter ended December 31, 2011. Cardica,s management will ... to discuss the financial results and provide an update on ... progress on bringing our MicroCutter product line to the marketplace," ...
... 2012  A recent discovery by Van Andel Research Institute ... proposed drug therapies for glioblastoma – the most common ... The study, published in January in the ... , investigated glioblastoma models characterized by cell signaling activation ...
Cached Medicine Technology:Cardica Announces Fiscal 2012 Second Quarter Financial Results 2Cardica Announces Fiscal 2012 Second Quarter Financial Results 3Cardica Announces Fiscal 2012 Second Quarter Financial Results 4Cardica Announces Fiscal 2012 Second Quarter Financial Results 5Cardica Announces Fiscal 2012 Second Quarter Financial Results 6Discovery Predicts Patient Sensitivity to Important Drug Target in Deadly Brain Cancer 2
(Date:7/7/2015)... ... July 07, 2015 , ... Nationally-renowned attorneys in ... new website, the Invokana Ketoacidosis Lawsuit Center . The website provides information ... resource for persons wishing to learn more about Invokana lawsuits for kidney problems, ...
(Date:7/7/2015)... ... 07, 2015 , ... CSG Government Solutions, a ... the Department of Vermont Health Access to provide Quality Assurance (QA) and Independent ... Integrated Contact Center System project. , Vermont is implementing a strategic approach to ...
(Date:7/6/2015)... ... 2015 , ... Respected southern California personal injury attorney Fernando D. Vargas has ... attorney who has sharp legal skills as well as a superior commitment to client ... Martindale-Hubbell and a Top 10 Award from The National Academy of Personal Injury Attorneys ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... On June 22, 2015, Fox News in a report titled “ Female ... time they turn age 35 a quarter of all women in the U.S. will suffer from ... is stigmatized and rarely discussed. One woman, a former beauty queen, who was interviewed ...
(Date:7/6/2015)... ... July 06, 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics ... to grow at a CAGR of over 3.2 percent in the years to come ... to be mainly spurred by an anticipated launch of a number of promising pipeline ...
Breaking Medicine News(10 mins):Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 3Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2
... at a leading medical centre.// Those behind the project are ... months., ,"The trials on mice to establish the ... States and by August this year we should be able ... of haematology and oncology told reporters at Kolkata., ,Prof ...
... appropriate weight, according to current guidelines,// are four times ... have a baby who becomes overweight in early childhood. ... Department of Ambulatory Care and Prevention of Harvard Medical ... in the April issue of the American Journal of ...
... impairs endogenous pain-inhibitory function and increases spontaneous pain in ... disturbance in chronic pain, according to a study published ... ,The study, conducted by Michael T. Smith, PhD, ... healthy females, who were studied polysomnographically for seven nights. ...
... men decline as they get older. As sleep quality and ... amount of sleep a healthy older man gets can affect ... study published in the April 1st issue of the journal ... MD, PhD, of the University of Chicago, focused on 12 ...
... sounded an alert by restricting the entry// of poultry from ... of bird flu, officials said Monday. ... borders with either Bangladesh or Myanmar have asked customs officials ... countries. ,'We are worried as we have ...
... signed an outsourcing deal with India's Tata Consulting Services ... ,A company statement said that under ... global clinical research and development programme by providing outsourced ... ,The arrangement will create nearly 100 new jobs on ...
Cached Medicine News:Health News:Weight Gain in Pregnancy Linked to Overweight in Kids 2Health News:Weight Gain in Pregnancy Linked to Overweight in Kids 3Health News:New Study in SLEEP Finds That Sleep Disturbance Increases Spontaneous Pain in Women 2Health News:Sleep Quantity Affects Morning Testosterone Levels in Older Men 2
Wire mesh braided design with a platinum core....
... Finnpipette Focus multichannel pipettes ... of reagents into microplates, ... 0.1-10 l volumes. The ... Finnpipette Focus multichannels, combined ...
... The Finnpipette Digital Multichannel, ... even lighter work of routine ... all these advanced features: Soft-touch ... micro volume pipetting (0.5-10ul models), ...
... and Benefits: 1-12channel pipette This ... product number, created to easily ... showing no availability yet, please ... number (Z37,173-4) or contact customer ...
Medicine Products: